Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
P169: 90-month efficacy outcomes with cipaglucosidase alfa plus miglustat in adults with Pompe disease in ATB200-02: An open-label phase I/II study | Researchclopedia
Back to research
P169: 90-month efficacy outcomes with cipaglucosidase alfa plus miglustat in adults with Pompe disease in ATB200-02: An open-label phase I/II study
2026
0 citations
Journal Article
diamond Open Access
Field-Weighted Citation Impact:
0.00
Nadine van der Beek
·
Erasmus MC
Farah Amon
·
Amicus Therapeutics (United States)
Brian Fox
·
Amicus Therapeutics (United States)
Fred Holdbrook
·
Amicus Therapeutics (United States)
Vipul Jain
·
Amicus Therapeutics (United States)
Benedikt Schoser
·
Friedrich Baur Stiftung